BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹35.95
- Market cap
- ₹34.73 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 14.3×Sector 45.9×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other debt & borrowing announcements
All →Aptus Value Housing Finance India Debt & Borrowing: ₹0.89 Cr
Aptus Value Housing paid Rs.0.89 Crore monthly interest on its NCDs (ISIN INE852O07162) on 2 November 2026. The payment fulfils the scheduled coupon on Rs.150 Crore secured debentures.
- Value
- ₹0.89 Cr
HDB Financial Services Debt & Borrowing: ₹26.2 Cr
HDB Financial Services paid ₹26.20 Crore of interest on its Series 2024/18 subordinate bonds on 2 November 2026. This is routine servicing of existing debt obligations.
- Value
- ₹26.20 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.06 Cr
Moneyboxx Finance paid ₹0.06 crore of monthly interest on its listed NCDs on October 31, 2026. The payment relates to ₹25 crore of secured debentures carrying 12% interest.
- Value
- ₹0.06 Cr
Magnum Ventures Debt & Borrowing: ₹1.65 Cr
Magnum Ventures paid Rs 1.65 Crore monthly NCD interest across two series on time. Payment was made October 26, 2026, ahead of the October 31 due date.
- Value
- ₹1.65 Cr
Sadhav Shipping Debt & Borrowing: ₹10 Cr
Sadhav Shipping approved a Rs. 10 crore term loan from Bajaj Finance Limited, secured against vessel AHTS Saroja Blessing. It carries 9.75% interest over 48 months.
- Value
- ₹10.00 Cr
- Execution
- 48 months, including a 3-month moratorium
Sakthi Finance Debt & Borrowing: ₹3.29 Cr
Sakthi Finance certified timely payment of ₹3.29 Crore monthly interest across 17 NCD tranches for October 2026. All payments were made on the due date.
- Value
- ₹3.29 Cr